Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CytoDyn Inc CYDY

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The Company is studying leronlimab in multiple therapeutic areas, including... see more

Bullboard (OTCQB:CYDY)

View:
Post by tikotikoon Jun 21, 2020 6:42pm

Ready for takeoff

CYDY's share price increased by over 20% this week.  If the company shows good test results next month and gets FDA approvalsoon, it will easily get to at least $5 or much higher.  I ...more  
Post by flashme1on Jun 14, 2020 9:56pm

you all die off with covid-19

pretty quiet out there wheres all the chatter bugs now not the time to give up on cydy now only up from here 
Post by sunny3999on May 25, 2020 10:13am

Comparison David (Cytodyn) against Goliath (Gilead):

https://investorshangout.com/post/view?id=5777103
Post by sunny3999on May 25, 2020 10:13am

San Francisco Chronicle:

Bay Area search for coronavirus drugs extends far beyond remdesivir By J.D. Morris 2 hrs ago https://www.msn.com/en-us/Health/medical/bay-area-search-for-coronavirus-drugs-extends-far-beyond ...more  
Post by sunny3999on May 23, 2020 1:09am

CytoDyn to Hold Conference Call to Provide Updates on COVID

CytoDyn to Hold Conference Call to Provide Updates on COVID-19 (Phase 2, 3 & eIND), Cancer (mTNBC, Phase 2 for 22 Solid Tumor Cancers), HIV (BLA, Monotherapy), NASH, GvHD and MS  May 22 ...more  
Post by sunny3999on May 22, 2020 3:41pm

COVID-19 Insights: Leronlimab (Youtube Dr. Been)

Drbeen Medical Lectures 163.000 Follower COVID-19 Insights: Leronlimab   A good comprehensive article https://www.genengnews.com/covid-19-candidates/cytodyn/   A study on COVID ...more  
Post by sunny3999on May 22, 2020 2:46pm

Dr. B. Patterson Presentation at Beckman Coulter with Notes:

Dr. Bruce Patterson thanks Beckman Coulter for the invitation. He wants to talk about Rantes/CCL5. These are levels we've never seen before in Covid patients. How do these immune cells get to ...more  
Post by sunny3999on May 16, 2020 5:03pm

COVID-19 Research Symposium vom May 19-21 with Dr. Patterson

Bruce Patterson, M.D. Disruption of the CCL5/RANTES-CCR5 Pathway 1 Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19 CEO, IncellDx, California, USA 12:00 - 12:30 pm  ...more  
Post by sunny3999on May 16, 2020 4:41pm

COVID-19 and Cancer: a Comprehensive Review

Not sure this was posted it mentions Leronlimab.   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206576/
Post by sunny3999on May 15, 2020 7:15am

News:CytoDyn to Offer No-Cost Exploratory Laboratory Testing

https://www.cytodyn.com/newsroom/press-releases/detail/431/cytodyn-to-offer-no-cost-exploratory-laboratory-testing-for CytoDyn to Offer No-Cost Exploratory Laboratory Testing for Childhood ...more  
Post by sunny3999on May 14, 2020 1:08pm

Cytodyn named top 4 choices for a possible corona crisis win

Regeneron: Market capitalization $ 64 billion Gilead Sciences: Market capitalization $ 96.7 billion GlaxoSmithKline: Market capitalization $ 96.5 billion   far behind (ironically meant ...more  
Post by sunny3999on May 14, 2020 6:03am

Wow - a must read!

Excerpt: Then there’s Samsung’s biopharmaceutical arm, Samsung Biologics. In the first quarter of this year, ending in March, sales for Samsung Electronics rose 5.6 percent year over year, while sales ...more  
Post by sunny3999on May 14, 2020 4:38am

Excellent! Leronlimab: The Ultimate Solution for Corona Viru

Excellent! Leronlimab: The Ultimate Solution for Corona Virus | Syska Series | Ep. 12   {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/embed/IDSmPY7kCA4|(fs ...more  
Post by sunny3999on May 14, 2020 3:47am

CytoDyn NEXT SUPER STOCK livestream 5/13/20. Leronlimab

CytoDyn (CYDY) NEXT SUPER STOCK livestream 5/13/20. Leronlimab COVID-19 treatment update. {^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com/watch?v=Dg-PCkcn0Bw|(fs)True ...more  
Post by WallstreetPRon May 12, 2020 10:07am

The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)

The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has priority. It’s not a genuine public debate – if you ...more